Breast cancer patients and healthy women had a similar distribution of CD14 and CD16 markers in monocyte subpopulations, indicating that these two monocyte surface markers do not reflect the effect of breast cancer on monocytes, and a deeper analysis of the subpopulations and whole transcriptome is needed (Table 1). This evidence concerns the gene CD14 and breast carcinoma.